This summer Centerline Biomedical has partnered with Ohio Third Frontier as a part of their Diversity & Inclusion Technology Internship Program. This program is geared towards matching college students with early-stage technology companies to give them a real-world field related experience as well as business and entrepreneurial experiences.
Centerline Biomedical, a Cleveland Clinic spinoff, is part of this Wall Street Journal story about tech advances that are making the operating room “smarter, more effective — and a lot less risky for patients.”
Waiting for FDA clearance for your medical device can definitely feel like an eternity, but it’s important to be aware of what not to do during this process.
Complex endovascular procedures can result in higher radiation doses for both the patient and the caregiver, with variation based on several different parameters.
As we continue preparing to meet with investors, strategic partners and companies in 2018, we have successfully completed a fifth preclinical study to evaluate our surgical navigation system, IOPS.
From October 23-25, Centerline attended the 15th Annual Medical Innovation Summit hosted by Cleveland Clinic Innovations. This year’s conference was centered around genomics, precision medicine and market-ready technologies that will advance patient care.
On Wednesday, October 18th, Centerline Biomedical was featured at the CVilleBioHub forum on medical devices. Speakers highlighted recent advances in the medical device sector, specifically touching on guidance systems for therapeutic purposes and navigation during procedures.